November 3, 2025

Quest Diagnostics (DGX) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Quest Diagnostics Incorporated (NYSE: DGX) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a commanding market cap of $19.57 billion, Quest..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.6% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $12.25 billion, this company has made significant..

Abbott Laboratories (ABT): Investor Outlook with a 16.86% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry with a market capitalization of approximately $214.96 billion, continues to be a significant player in the medical devices sector. As..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotechnology Powerhouse with 149% Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out as a formidable player within the biotechnology sector, emphasized by its impressive market capitalization of $60.25 billion. The company’s strategy centers around the..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 23.28% Potential Upside with Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a rising star in the healthcare sector, is capturing investor attention with its robust portfolio and diverse segment offerings. With a market capitalization of $11.97 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 39.64% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a leading player in the Health Information Services industry, is making waves in the market with its robust cloud-based software solutions for healthcare payments. Founded..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 10% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical technology industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s growth. With a market..

Moderna, Inc. (MRNA) Stock Analysis: Unveiling a 48% Upside Potential Amidst Industry Challenges

In the fast-evolving biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) stands as a noteworthy player, particularly recognized for its pioneering messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, this U.S.-based company..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 3.23% Dividend Yield and Strong Revenue Growth

Novartis AG (NYSE: NVS), a leading player in the global healthcare sector, has long been a staple for investors seeking exposure to the drug manufacturing industry. Headquartered in Basel, Switzerland,..

Exelixis, Inc. (EXEL) Investor Outlook: A Biotech Powerhouse with a 13.51% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a pioneering force in oncology, continues to capture the attention of investors with its focus on developing innovative treatments for challenging cancers. Headquartered in Alameda, California,..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking the 10% Potential Upside with Strong Buy Ratings

For investors eyeing the dynamic intersection of technology and healthcare, Veeva Systems Inc. (NYSE: VEEV) presents a compelling opportunity. With a robust market capitalization of $47.73 billion, Veeva Systems stands..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook on Growth Potential and Analyst Consensus

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a stalwart in the healthcare sector, remains a focal point for investors due to its robust position in the specialty and generic drug manufacturing..

Ascendis Pharma A/S (ASND) Stock Analysis: A 23.69% Upside Powered by Robust Revenue Growth

For investors seeking exposure to the dynamic biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity. With a market capitalization of $12.21 billion and a focus on innovative..

HealthEquity, Inc. (HQY): Analyst Consensus Reveals 28.76% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services industry, has been catching the eye of investors with its robust growth prospects and a compelling potential upside..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unveiling a 36.67% Upside Potential

Investors eyeing the healthcare sector might find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) an intriguing prospect, particularly given its robust potential for growth. With a market capitalization of $8.35 billion, Jazz..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and 14.82% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the drug manufacturers’ industry specializing in both specialty and generic drugs. With a market capitalization of $19.18..

DaVita Inc. (DVA) Stock Report: Examining the 21% Potential Upside for Investors

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, specifically within the medical care facilities industry, has garnered attention with its robust potential for growth and strategic positioning...

argenx SE (ARGX) Stock Analysis: Exploring the 12.12% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a dynamic player in the biotechnology sector, continues to capture investor attention with its promising pipeline and significant market presence. As a commercial-stage biopharma company, argenx..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 7.74% Potential Upside for Investors

Doximity, Inc. (NYSE: DOCS) has positioned itself as a formidable player within the healthcare sector, specializing in health information services. With a market capitalization of $12.36 billion, Doximity has carved..

ResMed Inc. (RMD) Stock Analysis: Unveiling an 18.87% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector specializing in medical instruments and supplies, presents an intriguing prospect for investors seeking growth in the medical device industry. With..

Search

Funds

November 3, 2025

Search

Funds

November 3, 2025

FTSE 100

Funds